Lv3
328 积分 2026-01-27 加入
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
5个月前
已完结
CT-121: Phase 3 Study of the Efficacy and Safety of Iptacopan (LNP023), an Oral Factor B Inhibitor, in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naïve to Complement Inhibitor Therapy
5个月前
已完结
Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial
5个月前
已完结
Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial
5个月前
已关闭
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria
5个月前
已完结
Enhanced Recovery After Surgery Protocols for Open Hepatectomy—Physiology, Immunomodulation, and Implementation
6个月前
已完结
Oxidative Stress and Liver Ischemia–Reperfusion Injury
6个月前
已完结
Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia
6个月前
已完结
Effectiveness of polyene phosphatidylcholine and its combination with other drugs in patients with liver diseases based on real-world research
6个月前
已完结
High Preoperative Serum Alanine Transferase Levels: Effect on the Risk of Liver Resection in Child Grade A Cirrhotic Patients
6个月前
已完结
皖公网安备34019202002308
